Clinical Approaches Toward Tumor Angiogenesis: Past, Present and Future
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
3820-3834
Author(s):
Yasuyuki Fujita, Riichiro Abe and Hiroshi Shimizu
Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
Journal:
Current Drug Metabolism
Volume:
9
Page:
1063-1120
Author(s):
C. Ulbricht, W. Chao, D. Costa, E. Rusie-Seamon, W. Weissner and J. Woods
Antitumor Activity of Oxali-Titanocene Y in Xenografted CAKI-1 Tumors in Mice
Journal:
Letters in Drug Design & Discovery
Volume:
5
Page:
489-493
Author(s):
Iduna Fichtner, Diana Behrens, James Claffey, Brendan Gleeson, Megan Hogan, Denise Wallis, Holger Weber and Matthias Tacke
Application of MALDI/SELDI Mass Spectrometry to Cancer Biomarker Discovery and Validation
Journal:
Current Proteomics
Volume:
5
Page:
224-252
Author(s):
Farid E. Ahmed
Recent Advances in the Development of Multi-Kinase Inhibitors
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
8
Page:
1312-1327
Author(s):
Martin Krug and Andreas Hilgeroth
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2983-2998
Author(s):
Eyal Mishani, Galith Abourbeh, Martin Eiblmaier and Carolyn J. Anderson
The Role of Amino Acids in the Modulation of Cardiac Metabolism During Ischemia and Heart Failure
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
2592-2604
Author(s):
Giuseppe Marazzi, Salvatore Rosanio, Giuseppe Caminiti, Francesco Saverio Dioguardi and Giuseppe Mercuro
Novel Therapeutic Options in Metastatic Renal Cancer – Review and Post ASCO 2007 Update
Journal:
Reviews on Recent Clinical Trials
Volume:
3
Page:
212-216
Author(s):
Stephan Kruck, Markus A. Kuczyk, Georgios Gakis, Mario W. Kramer, Arnulf Stenzl and Axel S. Merseburger
Targeting Angiogenesis in Renal Cell Carcinoma
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
349-358
Author(s):
Georgios Lainakis and Aristotle Bamias
The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Journal:
Current Cancer Therapy Reviews
Volume:
4
Page:
227-234
Author(s):
Arun Rajan and Ajeet Gajra